help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghazali, A.
Right arrow Articles by Fournier, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghazali, A.
Right arrow Articles by Fournier, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 1 32-38
Copyright © 1997 by The Endocrine Society


Clinical Studies

Low Bone Mineral Density and Peripheral Blood Monocyte Activation Profile in Calcium Stone Formers with Idiopathic Hypercalciuria1

A. Ghazali, V. Fuentès, C. Desaint, P. Bataille, A. Westeel, M. Brazier, L. Prin and A. Fournier

Department of Nephrology-Internal Medicine (A.G., P.B., A.F.), Laboratory of Immunology (V.F., C.D., P.L.), Radiology Department (A.W.), Faculty of Pharmacy (M.B.), Centre Hospitalier Universitaire Amiens-Hôpital Sud, 80054 Amiens Cedex 1, France

Address all correspondence and requests for reprints to: Professor A. Fournier, Department of Nephrology-Internal Medicine, Centre Hospitalier Universitaire Amiens-Hôpital Sud, Avenue Laennec-Salouel, 80054 Amiens Cedex 1, France.

Calcium stone formers (CaSF) with idiopathic hypercalciuria (IH) have been shown to have decreased bone mineral density (BMD). The mechanism of their bone loss remains obscure. Monokines like interleukin-1ß (IL-1ß), IL-6, tumor necrosis factor-{alpha} (TNF-{alpha}), and granulocyte macrophage stimulating factor (GM-CSF) are involved in bone remodeling, but only IL-1 excess has been incriminated in the bone loss of CaSF with IH. Therefore, to more precisely delineate the role of monocyte activation in the pathogenesis of bone loss in these patients, we studied the production of IL-1ß, IL-6, TNF-{alpha}, and GM-CSF by unstimulated or lipopolysaccharide (LPS)-stimulated cultured peripheral blood monocytes in 15 CaSF with IH, in 10 CaSF with dietary calcium-dependent hypercalciuria (DH), and in 10 healthy controls (C). Cytokines were measured in the culture medium by sensitive enzyme-linked immunosorbent assay and vertebral BMD by single energy computed tomography. The decrease of vertebral BMD in IH compared with DH, was confirmed (Z score: -1.2 ± 0.2 vs. -0.5 ± 0.2; P = 0.04; Mann-Whitney). In the supernatant of unstimulated peripheral blood monocytes, IL-1ß and TNF-{alpha} levels were higher in IH than in C (respectively, 40 ± 21 vs. 7 ± 1 pg/mL, P = 0.008 and 236 ± 136 vs. 39 ± 23 pg/mL, P = 0.03); those of GM-CSF were greater in IH than in DH and C (respectively, 52 ± 27 vs. 6 ± 2, P = 0.04 and 6 ± 2 pg/mL, P = 0.01) and those of IL-6 were not significantly different among the groups. After in vitro stimulation by LPS (10 µg/mL), the levels of the various monokines were not significantly different. In IH patients, the post-LPS levels of IL-6 were negatively correlated to vertebral BMD (n = 15, Z = -1.97, P = 0.04; Spearman), whereas those of GM-CSF were positively related to vertebral BMD (n = 15, Z = 2.01, P = 0.04).

In this study, calcium stone formers with IH have bone mineral decrease and a particular profile of peripheral blood monocytes activation. This latter is characterized by a spontaneously increased synthesis of IL-1ß, TNF-{alpha}, and GM-CSF. Furthermore, post-LPS levels of IL-6 and GM-CSF are correlated with vertebral BMD. These results suggest that monocyte activation may be involved in the bone loss of calcium stone formers with IH.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Pasch, F. J. Frey, U. Eisenberger, M. G. Mohaupt, and O. Bonny
PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers
Nephrol. Dial. Transplant., April 8, 2008; (2008) gfn091v1.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Favus, A. J. Karnauskas, J. H. Parks, and F. L. Coe
Peripheral Blood Monocyte Vitamin D Receptor Levels Are Elevated in Patients with Idiopathic Hypercalciuria
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4937 - 4943.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. ARIS, A. R. STEPHENS, D. A. ONTJES, A. DENENE BLACKWOOD, R. K. LARK, M. B. HENSLER, I. P. NEURINGER, and G. E. LESTER
Adverse Alterations in Bone Metabolism Are Associated with Lung Infection in Adults with Cystic Fibrosis
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1674 - 1678.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
J. S. Adams, C. F. Song, and V. Kantorovich
Rapid Recovery of Bone Mass in Hypercalciuric, Osteoporotic Men Treated with Hydrochlorothiazide
Ann Intern Med, April 20, 1999; 130(8): 658 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Thomas
Low BMD in Calcium Stone Formers with Hypercalciuriak
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1401a - 1402.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society